Karl Harbin
Obstetrics & Gynecology · Tuscaloosa, ALNPI 1295721157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $991 and has fallen 98.1% since, to $19 in 2024.
Across 133 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$310
- Astellas Pharma US Inc$192
- Roche Diagnostics Corporation$186
- Pfizer$145
- Amgen$124
- Hologic Sales And Service, LLC$121
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,17594%
- Education$1416%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $310 |
| Astellas Pharma US Inc | 7 | $192 |
| Roche Diagnostics Corporation | 10 | $186 |
| Pfizer | 10 | $145 |
| Amgen | 9 | $124 |
| Hologic Sales And Service, LLC | 8 | $121 |
| Sumitomo Pharma America, Inc. | 7 | $118 |
| Myovant Sciences Inc. | 7 | $111 |
| Organon | 4 | $100 |
| Scynexis, Inc. | 5 | $89 |
| Daiichi Sankyo Inc. | 4 | $80 |
| Mayne Pharma Commercial LLC | 5 | $80 |
| Bayer | 4 | $57 |
| Urovant Sciences Inc | 3 | $53 |
| Evofem Biosciences, Inc. | 3 | $49 |
| Coopersurgical, Inc. | 3 | $46 |
| Exeltis, USA Inc. | 2 | $38 |
| Merck | 3 | $36 |
| Avion Pharmaceuticals | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Minerva Surgical, Inc | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 2 | $29 |
| Duchesnay USA Incorporated | 2 | $28 |
| BD | 1 | $28 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Therapeuticsmd, Inc. | 2 | $26 |
| KCI USA, Inc. | 1 | $24 |
| Axonics, Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $19 |
| Intuitive Surgical | 1 | $17 |
| Gilead | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
How this compares
$2,315 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $380 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $199 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tuscaloosa
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Praful PatelDothan$65K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- Francois BlaudeauHomewood$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.